Mbxbio MBX Biosciences is a biopharmaceutical company developing precision peptide therapies for endocrine and metabolic disorders through its proprietary PEP™ platform.
Jobs
See all jobs for Mbxbio here.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Series C
$63.5M$316.7M post-money valuation
Series B
Series A
$36.8M$61.4M post-money valuation